Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux

About this trial

CiGal-EI-TEP is an exploratory study that aim to assess the diagnostic performance of 68Ga Positron emission tomography (PET) / Computed Tomography (CT) for the diagnosis of prosthetic valve infective endocarditis in comparison with the final diagnosis established according to the ESC 2023 criteria, after 3 months of follow-up, by a panel of experts.

Eligibility criteria

Qualifiers

adult patient (over 18 years old);

patient with a prosthetic heart valve;

patient suspected of infective endocarditis (on clinical and/or microbiological and/or imaging data);

patient whose history is discussed in the multidisciplinary meeting dedicated to endocarditis;

Disqualifiers

pregnant or breastfeeding women;

women of childbearing potential not using effective contraception;

patients referred to in articles L.1121-5 to L.1121-8 (persons deprived of liberty by judicial or administrative decision, minors, adults subject to a legal protection measure or unable to express their consent);

subject in a period of relative exclusion due to another protocol;

Trial design

Treatments tested in this trial

  • 68Ga-citrate PET/CT

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators